Model
Dmitri Model, Toronto CA
Patent application number | Description | Published |
---|---|---|
20140211995 | POINT-OF-GAZE ESTIMATION ROBUST TO HEAD ROTATIONS AND/OR ESTIMATION DEVICE ROTATIONS - Point-of-gaze of a user looking at a display is estimated, taking into account rotation of the user's head or rotation of the display. An image of an eye of the user is captured. The image is processed to determine coordinates in the image of defined eye features, sufficient to determine the eye's optical axis. At least one angle is determined, the at least one angle proportional to an angle between (i) a line coincident with an edge of the display and (ii) an intersection of the sagittal plane of the user's head with a plane of the display. An intersection of the eye's line-of-sight with the plane of the display is estimated using the eye's optical axis, and using the at least one angle to account for rotation of the user's head or the display. | 07-31-2014 |
Fabian Model, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20080311566 | Method for Quantification of Methylated Dna - The present invention relates to a method for the quantification of methylated cytosines in DNA. In the first step of the invention unmethylated cytosines in the DNA to be analysed are chemically converted into uracil while 5-methylcytosines remain unchanged. In a second step the converted DNA is amplified methylation specifically in a real time PCR using a methylation specific probe. Finally the amount of uniformly methylated DNA is calculated by combining criteria derived from the shape of the real time curve and from the signal intensity. The method is preferably used for diagnosis and/or prognosis of adverse events for individuals, for distinguishing cell types and tissues, or for investigating cell differentiation. | 12-18-2008 |
Fabian Model, Penzberg DE
Patent application number | Description | Published |
---|---|---|
20130143210 | METHOD FOR THE PROGNOSIS OF OVARIAN CARCINOMA - The invention relates to a method for determining prognosis of subjects with ovarian carcinoma using a biological sample comprising genomic tumor DNA isolated from the subject. According to the invention, the method comprises the steps of: determining the methylation status of a CpG dinucleotide in a target sequence that is selected from the group consisting of the target sequences as referred to by name in Table 1 in a biological sample isolated from a subject; and deducing from the determined methylation status of the target sequence the prognosis of subject with ovarian carcinoma. The improved prognosis determination of the subject with ovarian carcinoma enables the improved treatment of the said patient. | 06-06-2013 |
20140065610 | METHOD FOR PREDICTING CLINICAL BENEFIT IN THE TREATMENT OF NEURODEVELOPMENTAL, NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS - An in vitro method of predicting whether a patient, having a neurodevelopmental, neurological or neuropsychiatric disorder, will derive a clinical benefit if treated with a glycine reuptake inhibitor (GRI), via determination of the protein concentration of one, two, three, four five or six members of the complement factor H family or a mixture or a combination thereof and comparison against a representative value, wherein a higher value of the protein concentration in the patient's sample against the representative value is indicative of a patient whom will derive clinical benefit from treatment with GRI. | 03-06-2014 |
Jeffrey Model, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20110146692 | Implant Delivery Device - Devices and methods are disclosed for the delivery of a compressible implant into a bodily lumen. The delivery device includes an enlarged section that is configured to house the implant during delivery thereof into a patient. In certain embodiments, the implant is kept within the delivery device in a substantially uncompressed configuration prior to the delivery thereof. | 06-23-2011 |
20110180073 | Sterilization Device and Method - Sterilization devices and methods for deploying porous implants within the fallopian tubes are disclosed. The devices include a catheter component including an external electrode sheath containing at least two deployable implants and a positioning member. Sliding the external sheath proximally disposes the implants within the fallopian tubes, while sliding both the positioning member and external electrode sheath distally reloads a second implant into the external electrode sheath. The devices further includes a handle component, which houses a chassis, external electrode sheath carrier, reciprocating shaft, positioning member carrier and first and second engaging members. The reciprocating shaft may be operated by a motor to slide distally and proximally along a long axis. The reciprocating shaft, external electrode sheath and its carrier, upon selective actuation, move together proportionally to deploy and reload the implants to facilitate occlusion of the fallopian tubes and complete sterilization. | 07-28-2011 |
20120111336 | IMPLANT DELIVERY DEVICE WITH EXPANDING TIP - Devices and methods are disclosed for the delivery of an implant into small bodily spaces. The delivery devices include an expandable portion configured for placement within such bodily spaces and subsequent expansion to facilitate the delivery of the implant. | 05-10-2012 |
20120266892 | TETHERED IMPLANT AND RELATED METHOD OF USE - An implant configured for insertion and placement within a fallopian tube of a female during a sterilization procedure. The implant includes an implant body having proximal and distal ends and a tether. The tether is attached to the implant body and extends a distance away from the implant body. The tether may be bioabsorbable and/or detachably coupled to the implant body so that the tether can be separated from the implant body without dislodging the implant body from the fallopian tube. | 10-25-2012 |
20130239975 | IMPLANT DELIVERY DEVICE - Devices and methods are disclosed for the delivery of a compressible implant into a bodily lumen. The delivery device includes an enlarged section that is configured to house the implant during delivery thereof into a patient. In certain embodiments, the implant is kept within the delivery device in a substantially uncompressed configuration prior to the delivery thereof. | 09-19-2013 |
20140207133 | INTEGRATED PUMP AND GENERATOR DEVICE AND METHOD OF USE - The present disclosure relates to devices and methods for cooling of ablation technology used to treat tissue. The devices and methods disclosed herein utilize a generator assembly which includes an integrated cooling system, and a disposable subassembly which includes a disposable pump head and ablation device. | 07-24-2014 |
20140276726 | INTRAUTERINE TREATMENT DEVICE WITH ARTICULATING ARRAY - An intrauterine device includes an articulating array. The intrauterine device can be operated by articulating the articulating array into an installed position or geometry within the uterus of a patient. Further, the articulating array can be constructed to include an insertion geometry have a smaller cross section than an installation geometry. The articulating array can also be constructed to be housed within a sheath in the intrauterine device. Once the sheath has been inserted into a patient, for example through the patient's cervix, the articulating array can be deployed in its insertion geometry and then articulated into an installed position. The articulating array can include a plurality of expansion chambers. The expansion chambers can be constructed and arranged to take on the installed geometry when expanded. In one embodiment, the purpose of the articulating array is to position a conductive array within the patient's uterus enabling ablation of the uterine lining. | 09-18-2014 |
Michael A. Model, Chagrin Falls, OH US
Patent application number | Description | Published |
---|---|---|
20090027676 | MEASUREMENT OF THE ABSORPTION COEFFICIENT OF LIGHT ABSORBING LIQUIDS AND THEIR USE FOR QUANTITATIVE IMAGING OF SURFACE TOPOGRAPHY - An optical measurement system for obtaining information such as the absorption coefficient of a light-absorbing liquid, or a surface profile of an object immersed in a light-absorbing liquid having a known absorption coefficient. The system includes a light source that transmits light through the liquid, a detector that records an image of the light transmitted through the sample and a processor or other means adapted to analyze the intensity distribution found on the image to generate information about the sample. | 01-29-2009 |
Michael J. Model, Sachse, TX US
Patent application number | Description | Published |
---|---|---|
20100289576 | HIGH EFFICIENCY POWER AMPLIFIER POWER ARCHITECTURE - A distributed power converter is for use with an RF power amplifier and includes a primary converter connected to an input voltage and configured to provide a regulated DC intermediate voltage that is galvanically isolated from the input voltage. Additionally, the distributed power converter also includes a secondary regulator connected galvanically to the regulated DC intermediate voltage and configured to generate a regulated DC supply voltage for at least a portion of the RF power amplifier. In another aspect, a method of operating a distributed power converter is for use with an RF power amplifier and includes providing a regulated DC intermediate voltage that is galvanically isolated from an input voltage and generating a regulated DC supply voltage for at least a portion of the RF power amplifier that is galvanically connected to the regulated DC intermediate voltage. | 11-18-2010 |
20120212294 | HIGH EFFICIENCY POWER AMPLIFIER POWER ARCHITECTURE - A distributed power converter is for use with an RF power amplifier and includes a primary converter connected to an input voltage and configured to provide an unregulated DC intermediate voltage that is galvanically isolated from the input voltage. Additionally, the distributed power converter also includes a secondary regulator connected galvanically to the unregulated DC intermediate voltage and configured to generate a regulated DC supply voltage for at least a portion of the RF power amplifier. In another aspect, a method of operating a distributed power converter is for use with an RF power amplifier and includes providing an unregulated DC intermediate voltage that is galvanically isolated from an input voltage and generating a regulated DC supply voltage for at least a portion of the RF power amplifier that is galvanically connected to the unregulated DC intermediate voltage. | 08-23-2012 |
20120297104 | CONTROLLED INTERMEDIATE BUS ARCHITECTURE OPTIMIZATION - An intermediate bus architecture power system includes a bus converter that converts an input voltage into a bus voltage on an intermediate bus and a point-of-load converter that supplies an output voltage from the bus voltage on the intermediate bus. Additionally, the intermediate bus architecture power system includes a decision engine optimizing controller that controls a system variable to improve an overall system performance based on a monitored system variable or a system constraint. In another aspect, a method of operating an intermediate bus architecture power system includes converting an input voltage into a bus voltage on an intermediate bus and converting the bus voltage on the intermediate bus into an output voltage. The method also includes controlling a system variable to improve overall system performance based on a monitored system variable or a system constraint. | 11-22-2012 |